No Reported Renal Stones with Intravenous Vitamin C Administration: A Prospective Case Series Study

Abstract

A few cases associating high dose intravenous vitamin C (IVC) administration with renal stone formation have been reported in the literature, however, no long-term studies investigating IVC administration and reported renal stones have been carried out. Our aim was to measure the frequency of reported renal stones in patients receiving IVC therapy. We carried out a prospective case series study of 157 adult patients who commenced IVC therapy at Integrated Health Options clinic between 1 September 2011 and 31 August 2012, with follow-up for 12 months. Inquiries into the occurrence of renal stones were conducted at enrolment, 6 and 12 months, and renal function blood tests were conducted at enrolment, 4 weeks and every 12 weeks thereafter in a subgroup of patients. No renal stones were reported by any patients in the study, despite 8% of the patients having a history of renal stones. In addition, the majority of patients investigated had stable renal function during the study period as evidenced by little change in serum creatinine levels and estimated glomerular filtration rate (eGFR) following IVC. In conclusion, IVC therapy was not associated with patient-reported renal stones. Although not the primary focus of this study, it was also observed that there was no significant change in mean serum creatinine or eGFR for those who had follow-up renal function blood tests.

Beneficial aspects of high dose intravenous vitamin C on patients with COVID-19 pneumonia in severe condition: a retrospective case series study

“…Therefore, the safety profile of vitamin C should be concerned. The latest case serious study including 157 patients showed no renal stone was reported after temporary, intravenous, high dose application of vitamin C (33). In our study, no patient was observed to suffer any identifiable adverse event related with HDIVC.…”

Vitamin C Symposium 2019—“Vitamin C for Cancer and Infection: From Bench to Bedside”

“…In conclusion, IVC therapy was not associated with patient-reported renal stones. Although not the primary focus of this study, it was also observed that there was no significant change in mean serum creatinine or eGFR for those who had follow-up renal function blood tests [7]. Glioblastoma multiforme is a high-grade malignant brain tumour with a poor prognosis.…”

Evaluating extremely low plasma ascorbate levels and reduction of plasma ascorbate levels by dialysis in Japanese hemodialysis patients

“…Oxalate crystallization occurs at levels above 30 mM [30] and high plasma oxalate levels were seen in hemodialysis patients [31][32][33]. However, in a recent prospective case series exploring high-dose intravenous vitamin C (15-100 g) administration, increased vitamin C intake was not associated with any cases of symptomatic renal stones and kidney injury [34]. Moreover, significant side effects of vitamin C are not reported in any of the mentioned controlled trials, including the most recent VITAMIN randomized trial [35].…”